Role of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives
Cells · 2023
DOI: 10.3390/cells12040651 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Pernille Y Ø Nielsen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Danish Parkinson Foundation, Faculty of Health Sciences at the University of Southern Denmark.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a neurodegenerative disorder that has been associated with mitochondrial dysfunction, oxidative stress, and defects in mitophagy as well as α-synuclein-positive inclusions, termed Lewy bodies (LBs), which are a common pathological hallmark in PD. Mitophagy is a process that maintains cellular health by eliminating dysfunctional mitochondria, and it is triggered by ubiquitination of mitochondrial-associated proteins—e.g., through the PINK1/Parkin pathway—which results in engulfment by the autophagosome and degradation in lysosomes. Deubiquitinating enzymes (DUBs) can regulate this process at several levels by deubiquitinating mitochondrial substrates and other targets in the mitophagic pathway, such as Parkin. Moreover, DUBs can affect α-synuclein aggregation through regulation of degradative pathways, deubiquitination of α-synuclein itself, and/or via co-localization with α-synuclein in inclusions. DUBs with a known association to PD are described in this paper, along with their function. Of interest, DUBs could be useful as novel therapeutic targets against PD through regulation of PD-associated defects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark.
- Department of Neurology, Odense University Hospital, 5000 Odense, Denmark.
- BRIDGE-Brain Research Inter-Disciplinary Guided Excellence, Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark.
ORCID-Profile: Morten Meyer
Förderung
- The Danish Parkinson Foundation
- Faculty of Health Sciences at the University of Southern Denmark
Zitieren
APA
Nielsen, P. Y. Ø., Okarmus, J., & Meyer, M. (2023). Role of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives. Cells. https://doi.org/10.3390/cells12040651
Vancouver
Nielsen PYØ, Okarmus J, Meyer M. Role of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives. Cells. 2023. doi:10.3390/cells12040651
BibTeX
@article{Nielsen2023,
author = {Nielsen, Pernille Y Ø and Okarmus, Justyna and Meyer, Morten},
title = {Role of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12040651}
}
EUVIMED